Clinical trial
Glatiramer Acetate for Multiple Sclerosis With Autoimmune Comorbidities
NCT01456416
Study timeline
Study start (unknown)2011-09-01Date precision: month
Registry last updated2013-04-04
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Relapsing Remitting Multiple Sclerosisunresolved
Interventions
Sponsors & collaborators
University of Southern Californialead sponsor
Teva Pharmaceuticals USAcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01456416 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.